Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (abre una nueva ventana)

Brady KM, Easley RB, Tobias JD.

Fuente‎: Paediatr Anaesth 2006;16(10):1042-6.

Indexado en‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (abre una nueva ventana)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (abre una nueva ventana)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Fuente‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Indexado en‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (abre una nueva ventana)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (abre una nueva ventana)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Fuente‎: Pediatrics 2002;110(1 Pt 1):169-71.

Indexado en‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (abre una nueva ventana)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (abre una nueva ventana)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Fuente‎: Paediatr Drugs 2017;19(1):53-8.

Indexado en‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (abre una nueva ventana)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (abre una nueva ventana)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Fuente‎: J Perinatol 2011;31(3):188-92.

Indexado en‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (abre una nueva ventana)

Use of recombinant factor VIIa in infants with severe coagulopathy. (abre una nueva ventana)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Fuente‎: J Perinatol 2004;24(5):310-1.

Indexado en‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (abre una nueva ventana)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (abre una nueva ventana)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Fuente‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Indexado en‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (abre una nueva ventana)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (abre una nueva ventana)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Fuente‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Indexado en‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (abre una nueva ventana)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (abre una nueva ventana)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Fuente‎: Paediatr Anaesth 2009;19(4):364-70.

Indexado en‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (abre una nueva ventana)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (abre una nueva ventana)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Fuente‎: Spine 2004;29(12):1384-7.

Indexado en‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (abre una nueva ventana)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (abre una nueva ventana)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Fuente‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Indexado en‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (abre una nueva ventana)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (abre una nueva ventana)

Olomu N, Kulkarni R, Manco-Johnson M.

Fuente‎: J Perinatol 2002;22(8):672-4.

Indexado en‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (abre una nueva ventana)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (abre una nueva ventana)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Fuente‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Indexado en‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (abre una nueva ventana)